Skip to main content

RESMED INC

For the period ended Mar 31, 2026. Filed May 1, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 1, 2026

RMD$234.11-0.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Financial Information Financial Statements Condensed Consolidated Balance Sheets (Unaudited)

PART I – FINANCIAL INFORMATIONItem 1

Item 1. Financial Statements

Condensed Consolidated Balance Sheets (Unaudited)

(In US$ and in thousands, except share and per share data)

March 31,2026June 30,2025
Assets
Current assets:
Cash and cash equivalents$1,660,513$1,209,450
Accounts receivable, net of allowances of $29,474 and $22,424 at March 31, 2026 and June 30, 2025, respectively998,837939,492
Inventories (note 3)911,876927,711
Prepaid expenses and other current assets (note 3)492,836428,952
Total current assets4,064,0623,505,605
Non-current assets:
Property, plant and equipment, net (note 3)566,972550,790
Operating lease right-of-use assets161,602167,497
Goodwill (note 4)3,043,1363,046,680
Other intangible assets, net (note 3)425,185464,861
Deferred income taxes312,594253,119
Prepaid taxes and other non-current assets210,734185,839
Total non-current assets4,720,2234,668,786
Total assets$8,784,285$8,174,391
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable$273,301$278,157
Accrued expenses446,149402,253
Operating lease liabilities, current29,23330,506
Deferred revenue179,277166,030
Income taxes payable163,322132,274
Short-term debt, net (note 7)259,9289,900
Total current liabilities1,351,2101,019,120
Non-current liabilities:
Deferred revenue163,148156,803
Deferred income taxes77,92977,682
Operating lease liabilities, non-current149,840153,015
Other long-term liabilities146,079141,520
Long-term debt, net (note 7)404,168658,392
Total non-current liabilities941,1641,187,412
Total liabilities2,292,3742,206,532
Commitments and contingencies (note 9)
Stockholders’ equity:
Preferred stock, $0.01 par value, 2,000,000 shares authorized; none issued——
Common stock, $0.004 par value, 350,000,000 shares authorized; 190,866,303 issued and 145,040,224 outstanding at March 31, 2026 and 190,311,097 issued and 146,385,350 outstanding at June 30, 2025763761
Additional paid-in capital2,134,2312,033,599
Retained earnings6,958,7796,081,490
Treasury stock, at cost, 45,826,079 shares at March 31, 2026 and 43,925,747 shares at June 30, 2025(2,576,957)(2,073,292)
Accumulated other comprehensive loss(24,905)(74,699)
Total stockholders’ equity6,491,9115,967,859
Total liabilities and stockholders’ equity$8,784,285$8,174,391
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.